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Abstract
Evolutionary theory suggests that the force of natural selection decreases with age. To explore the extent to which this
prediction directly affects protein structure and function, we used multiple regression to find longevity-selected positions,
defined as the columns of a sequence alignment conserved in long-lived but not short-lived mammal species. We analyzed
7,590 orthologous protein families in 33 mammalian species, accounting for body mass, phylogeny, and species-specific
mutation rate. Overall, we found that the number of longevity-selected positions in the mammalian proteome is much
higher than would be expected by chance. Further, these positions are enriched in domains of several proteins that interact
with one another in inflammation and other aging-related processes, as well as in organismal development. We present as
an example the kinase domain of anti-Mu ¨llerian hormone type-2 receptor (AMHR2). AMHR2 inhibits ovarian follicle
recruitment and growth, and a homology model of the kinase domain shows that its longevity-selected positions cluster
near a SNP associated with delayed human menopause. Distinct from its canonical role in development, this region of
AMHR2 may function to regulate the protein’s activity in a lifespan-specific manner.
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Introduction
Despite a 10–100-fold difference in maximum lifespan (MLS),
most known mammal species show similar phenotypes of aging
[1]. This observation suggests that the genetic determinants of
mammalian aging and lifespan may be relatively plastic. The
classical evolutionary theory of antagonistic pleiotropy [2] posits
that aging is an effect of the decrease in selection pressure that
occurs after successful reproduction. Conversely, lifespan exten-
sion has been shown to occur when selection pressure increases in
later age [3]. Still relatively unexplored are the specific molecular
mechanisms that determine differences in mammalian lifespan.
Many mechanisms are possible and likely occur simultaneously,
including changes in the sequence, structure, function, and
expression of RNA and proteins.
Here, we focus on changes in proteins caused by fixed
substitutions. In this context, two recent studies [4,5] predicted a
simple consequence of the evolutionary theory: we might expect
that proteins necessary for long mammalian lifespan would have
fewer substitutions, i.e. show more conservation, in long-lived
versus short-lived species. Thus, it may be possible to identify
aging-related proteins (more specifically, families of orthologous
proteins) by inferring and comparing some measure of such
preferential substitutions, here called ‘‘longevity-selected posi-
tions’’, among the several dozen mammal species whose
proteomes are available. In particular, Jobson et al. [4] accom-
plished this from the perspective of classical genetics, applying to a
codon model a measure similar to the well-known dN/dS ratio
(reviewed in [6]). Two relevant features of their method were that
(1) species were binned as ‘‘long-lived’’ or ‘‘short-lived’’ based on
MLS and (2) in keeping with the conventional framework, the total
estimate of synonymous substitutions in a gene determined the
threshold for whether any particular codon position in that gene
was called longevity-selected.
In contrast, we start from the perspective of protein structure,
which emphasizes two concepts that may be useful to find
interesting longevity-selected positions. First, positions within a
protein are not interchangeable; whatever the estimated synon-
ymous substitution rate, a single nonsynonymous substitution in a
certain structural context can change a protein’s function.
Second, not all nonsynonymous substitutions are equal; rather,
a priori we should expect those amino acid substitutions that
commonly change biochemical function to matter most for the
function of a specific protein. Based on these observations, we
present a simple regression-based method to find longevity-
selected positions in orthologous protein families of mammals.
Our method employs the phylogenetic generalized least squares
framework (PGLS, equivalent to phylogenetic independent
contrasts; [7]) to relate, for each position (column) of a protein
alignment, the MLS of the species represented in the column to
the biochemical divergence of their residues from the residue of a
long-lived reference species. Two benefits of PGLS are that (1) it
is straightforward to control for common gerontological con-
founders, including species-specific mutation rate, body mass,
and shared phylogeny [8], and (2) we can naturally fit a
continuous variable such as MLS, removing the need to
arbitrarily bin species.
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selected positions, placing emphasis on their structural contexts.
Our results concern both the proteome as a whole and a specific
protein domain identified by our analysis, the kinase domain of
anti-Mu ¨llerian hormone type-2 receptor (AMHR2; kinase no-
menclature per [9]). AMHR2 is a receptor protein serine/
threonine kinase in the TGF-beta Receptor Type II (TGFBR2)
subfamily. The canonical role of AMHR2 is to inhibit the
Mu ¨llerian ducts during development of the male fetus, and
mutations cause the rare disease persistent Mu ¨llerian duct
syndrome (PMDS; [10]). More recently, a role for AMHR2 in
ovarian follicle development of the adult female has also been
identified [11], and this noncanonical function may be relevant to
our findings.
Materials and Methods
2.1. Selection of Positions to Analyze
We analyzed a selected subset of the OrthoMaM database
version 6, which comprises multiple sequence alignments (MSAs)
of 11,746 protein ortholog families from 36 mammalian species
[12]. Most of the sequences in the database were extracted from
low-coverage genomes, so completeness and quality of alignments
varied considerably. We first masked nonstandard isoforms and
other divergent subsequences using a sliding window-based
approach. Specifically, we excluded from further analysis any
subsequence of at least 10 residues in which every 10-residue
window had at least four residues each with less than 30%
sequence identity to the rest of its column. We also excluded the
three non-eutherian species due to high sequence divergence. Of
the remaining data, we selected for fitting only columns that (1)
included at least ten characters overall and (2) specifically included
characters for both human and shrew. We refer to this subset as
selected columns.
2.2. Column Correction, Fitting, and Analysis
We define fit columns as the subset of selected columns that have
at least three characters different from the human reference
character, and conserved columns as all other selected columns. We
independently fit each column in the fit subset to a phylogenetic
generalized linear model [7], as implemented in the R package
caper, version 0.4 [13]. Briefly, this framework assumes a
Brownian model of trait evolution and uses the method of
generalized least squares to perform multiple regression with
correction for global phylogenetic dependence, as indicated by the
mammalian supertree. Specifically, for each column we fit the
regression model.
Here, MLS are the maximum lifespans and mass the body
masses of each species as reported in AnAge version 11 [14].
B80mut are the BLOSUM80 scores for each nonhuman ortholog
character in the column versus the human ortholog character [15],
corrected for mutation rate as described below. We used caper’s
default parameter values, including fixed nonterminal branch
length multiplier (l) of 1 for phylogenetic correction. As the input
phylogeny, we used the mammalian supertree [16], which is
ultrametric. Fitting completed after running for one day on a
standard single processor (2.2 GHz, 16 GB RAM).
To control for each species’ overall mutation rate, we used an
approach similar to that of Li and de Magalha ˜es [5]. Specifically,
to estimate these mutation rates we constructed by maximum
likelihood (protml, [17]) a tree whose branch length was the
expected number of amino acid substitutions over all fit columns.
We used this tree to correct each BLOSUM80 score for the
mutation rate of its respective species s relative to human by
adding log10(ms/mref) to the score, where ms was the total tree
length of species s and mref was the tree length of human. We
restricted the range of each B80mut score to the standard range of
B80 scores attainable by its human character.
Each fit yielded both a longevity-selected slope, bMLS, and p-
value, pMLS. We defined as a longevity-selected position any column
with both bMLS.0 and pMLS,0.01. Conserved columns were
assigned bMLS=0 and pMLS=1.
For the large-scale analyses, in the human orthologs we
predicted secondary structure with PSIPRED [18]; differences in
composition were tested with Pearson’s x
2 test. Protein domain
definitions and other features were taken from Swiss-Prot [19] and
mapped to OrthoMaM alignments by aligning each Swiss-Prot
sequence to its human counterpart in OrthoMaM. Ontology
enrichment analysis was performed using the Functional Annota-
tion Clustering module of DAVID [20] with default parameters,
including the human genome as background. We report only
Benjamini-corrected p-values. For the rolling-window analysis of
positions, we included only contiguous blocks of 10 selected
positions.
To construct the randomized control dataset, for each species A
except human, we swapped MLS, body mass, and phylogenetic
label with those of one species B, which was randomly selected
without replacement. All alignments remained unchanged, mean-
ing that the same set of columns were fit in both the randomized
control and real sets.
2.3. Homology Modeling and Structural Analysis of
AMHR2
We created a homology model of AMHR2 with Modeler [21],
using as template the kinase domain of BMPR2 (PDB ID: 3G2F).
Homology models made with SWISS-MODEL [22], or using as
template the kinase domain of ACVR2B (PDB ID: 2QLU),
yielded similar results. Positional conservation was calculated with
AL2CO [23], using 3G2F as the structural model.
Results and Discussion
3.1. Due to Overall Conservation, Most Positions in the
Mammalian Proteome are Not Longevity-selected
To identify specific positions (i.e., alignment columns) in the
mammalian proteome that are conserved in long-lived but not in
short-lived species, we fit a generalized multiple regression model
to each position independently. Our overall approach followed
from the observation that many of the positions we sought were
distinguished by high correlation between (1) each species’ MLS
and (2) functional similarity of each species’ residue to that of a
long-lived reference species. We used human as the reference
species, both because it was the longest-lived mammal whose
sequence was available and because we had the best confidence in
the accuracy of its sequence. Figure 1 shows a simplified
conceptual example of our approach. Our method also accounted
for each species’s body mass and overall mutation rate relative to
human. We emphasize that we chose multiple regression not for
rigorous statistical reasons, but only as a computational tool to
help form new biological hypotheses.
In this manner, we fit selected columns among the proteomes
of 33 species (Figure 2), with MLS ranging from 3 y (shrew) to
90 y (human). Initially, we attempted to fit the entire unfiltered
OrthomMaM database. However, this effort yielded many
obvious false-positives driven by low sample size and data of
Longevity-Selected Protein Regions in Mammals
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exon-intron boundaries and alternate isoforms. For this reason,
we implemented several heuristic filters for selection. In
particular, because rodents are over-represented among the
short-lived species of OrthoMaM, we selected only columns
containing a character for shrew (Sorex araneus), the shortest-lived
non-rodent. (Sections 2.1 and 2.2 give precise definitions of the
sets selected, fit, and conserved.) Using these criteria, we verified that
most selected positions in the mammalian proteome (80%) are
conserved across all species (Table 1; also found previously [4,5]).
In particular, at least 10 of 261 genes in the GenAge database of
aging-related genes [24] have protein products that show near-
complete conservation in mammals ($90% ratio of conserved
positions to total human ortholog length), for example beta-
catenin (CTNNB1), valosin-containing protein (VCP), fibroblast
growth factor receptor 1 (FGFR1), and lamin A (LMNA). Thus, if
these genes contribute to differences in mammalian longevity, it
is likely via some mechanism other than structural differences in
their protein products.
3.2. Among Nonconserved Positions, Longevity-selected
Positions Occur More often than Expected by Chance
For each selected position, our fitting procedure yielded both a
longevity-associated slope (bMLS) and associated p-value (pMLS), as
well as corresponding measures for body mass (bmass and pmass).
Only those positions with significantly positive slope were called
longevity-selected (bMLS.0 and pMLS,0.01) or mass-selected (bmass.0
and pmass,0.01). There were no positions that were both longevity-
selected and mass-selected, suggesting that pMLS,0.01 was a
reasonable cutoff in general for our analyses.
Among positions with positive MLS slope, we analyzed the
distribution of p-values in order to determine whether proteome-
wide trends existed with regard to longevity-selected positions
(Figure 3). As a negative control, we also analyzed a matched set of
positions whose MLS, body mass, and phylogenetic position had
been randomly swapped (‘‘randomized control’’). If there were no
overall relationship between MLS and amino acid conservation,
then we would expect significant p-values to be no more common
than nonsignificant p-values after accounting for shared phylogeny
and body mass. This is indeed the case for the randomized control
(Figure 3B). However, for the real data (Figure 3A), positions with
more significant p-values are clearly overrepresented relative to
those with less significant p-values. These results indicate that
overall, longevity-selected positions in the mammalian proteome
are much more likely than would be expected by chance.
This finding is robust to several perturbations of the data (Figure
S1), including use of chimp as the reference instead of human
Figure 1. Conceptual example of our multiple regression
method applied to a single column (Y465 of AMHR2; full
result in Table S2). (left) Characters shown ordered by species MLS.
For each non-human species, we calculate the similarity score
(‘‘BLOSUM80’’) for the species’ amino acid character versus the human
character (here Y); e.g., this score for Tursiops would be the similarity
score for H versus Y, which is 2. (right) We then fit the MLS of all non-
human species to their similarity scores; e.g., Tursiops’ contribution to
this fit is the point (52, 2). Not shown are the steps to correct for
mutation rate and shared phylogeny, and the simultaneous fit of body
mass. For this column, the data provide relatively strong support for a
nonzero slope in the fit of similarity to MLS, even given trends in
mutation rate, phylogeny, and body mass, and so this position is
assigned a relatively significant p-value (pMLS,0.01).
doi:10.1371/journal.pone.0038595.g001
Rattus norvegicus − rat − 5
Mus musculus − mouse − 4
Dipodomys ordii − kangaroo rat − 10
Cavia porcellus − guinea pig − 12
Spermophilus tridecemlineatus − squirrel − 8
Ochotona princeps − pika − 7
Oryctolagus cuniculus − rabbit − 9
Gorilla gorilla − gorilla − 55
Homo sapiens − human − 90
Pan troglodytes − chimpanzee − 59
Pongo pygmaeus − orangutan − 59
Macaca mulatta − rhesus − 40
Callithrix jacchus − marmoset − 17
Tarsius syrichta − tarsier − 16
Otolemur garnettii − galago − 18
Microcebus murinus − mouse lemur − 18
Tupaia belangeri − treeshrew − 11
Bos taurus − cow − 20
Tursiops truncatus − dolphin − 52
Sus scrofa − pig − 27
Vicugna vicugna − vicuna − 32
Equus caballus − horse − 57
Canis lupus − dog − 24
Felis silvestris − cat − 30
Myotis lucifugus − little brown bat − 34
Pteropus vampyrus − ﬂying fox − 21
Erinaceus europaeus − hedgehog − 12
Sorex araneus − shrew − 3
Dasypus novemcinctus − armadillo − 22
Choloepus hoffmanni − sloth − 37
Procavia capensis − hyrax − 15
Loxodonta africana − elephant − 65
Echinops telfairi − tenrec − MLS 19 y
Figure 2. Phylogeny of species used in this study. Shown next to
each species’ node are its binomial, common name, and MLS.
doi:10.1371/journal.pone.0038595.g002
Table 1. Number of positions and alignments selected, fit,
and conserved, as defined in Sections 2.1 and 2.2.
subset columns (610
6) alignments
include human 7.01 12,746
a
–selected 3.64 7,708
a
––fit 0.73 7,590
a
––conserved 2.91 118
b
aNumber of alignments that include at least one position in the indicated
subset.
bNumber of alignments that include only conserved positions.
doi:10.1371/journal.pone.0038595.t001
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SUM80 scores (Figures S1D and S1E). We note that although
BLOSUM62 is more commonly used than BLOSUM80, in this
case BLOSUM80 is more appropriate because mammalian
proteomes typically have 80–90% sequence identity. The result
also holds for input in which all nonhuman primates except one
(here, rhesus) are omitted (Figure S1B), indicating that it is not an
artifact of primate over-representation in OrthoMaM. Almost all
(7,689/7,723) of the positions called significant in Figure 3A have
pMLS,0.05 in this control set, suggesting that its relative lack of
very significant pMLS values is simply due to fewer data available
for each position (n=26 versus 32 species available to fit). Finally,
as we would expect the result does not hold when dog, a shorter-
lived species, is used as the reference instead of human (Figure
S1C).
A plausible biological hypothesis to explain this overall
plethora of longevity-selected positions is that the evolution of
longer mammalian lifespan requires particular concerted patterns
of substitutions throughout the proteome that subtly affect
protein properties such as binding affinity, folding, and stability.
Consistent with this hypothesis is that relative to mouse (MLS
4 y), the proteome of naked mole rat (a rodent with MLS ,30 y)
is more resistant to urea-induced unfolding [25], suggesting
increased protein stability in the longer-lived rodent. An
analogous process requiring concerted patterns of substitution
may be the convergent evolution of hyperthermostability in
archaea and bacteria [26].
To determine overall trends in longevity-selected positions with
regard to structural features of the proteome, we created and
searched databases of both predicted secondary structure and
predicted disordered regions for the human proteome. Table 2
shows the secondary structure composition of the human genome
as a whole, as well as in the longevity-selected positions of both the
real fit data and the randomized control data. This table shows
two trends. The first trend is that, in both real and randomized
longevity-selected positions, random coils are overrepresented, at
the expense of a-helices and b-strands, relative to the human
proteome as a whole (x
2(2, n=7,702)=265.23, p,2.2e-16). This
is easily explained by the observation that sequence in random
coils tends to be less conserved than other sequence; thus, fit
positions will tend to be overrepresented in these regions.
The second trend is that, relative to randomized longevity-
selected positions, real longevity-selected positions are slightly
enriched in a-helices at the expense of b-strands (x
2(2,
n=7,702)=18.36, p=1.0e-4). The significance of this finding is
unknown, but it is possible that an abundance of a-helices imparts
extra stability to proteins and protein complexes, e.g. via coiled-
coil interactions [27].
3.3. Longevity-selected Positions are Enriched in Protein
Domains with Known Roles in Inflammation,
Development, and other Diverse Functions
The majority of longevity-selected positions are located in
regions of proteins that are unannotated and presumably
unstructured. Since these regions are generally of unknown
function at present, it is difficult to interpret the biochemical
significance of substitutions within them. Thus, to find longevity-
selected positions with the best likelihood of causing well-
characterized changes to protein structure and function, we next
narrowed our focus to known protein domains. Specifically, we
compiled a list of all 129 domains that contain at least two
longevity-selected positions. The 129 domains are contained in
114 proteins. Table S1 summarizes the proteins and domains, and
Table S2 shows data for each longevity-selected position in the
domains, including number of characters (i.e., species) fit and all
slopes and p-values. Five genes for the 114 proteins shown in these
tables are present in the GenAge database [24]: serine-protein
kinase ATM, ATM; serine/threonine protein kinase ATR, ATR;
breast cancer type 1 susceptibility protein, BRCA1; ATP-
dependent DNA helicase Q4, RECQL4; and DNA-dependent
protein kinase catalytic subunit, PRKDC. Functional annotation
clustering revealed that several of the 114 proteins belong to
functional classes that have been associated with aging (Table 3).
We give three examples. First, leukemia inhibitory factor receptor
Figure 3. Density histograms of pMLS values. A. Real data. B. Randomized control. Each histogram shows the n=734,741 fit positions with
bMLS.0. See Section 3.2 for details.
doi:10.1371/journal.pone.0038595.g003
Table 2. Predicted secondary structure in all positions of the human proteome and in two subsets of longevity-selected positions.
a-helix b-strand random coil total
human proteome 2,108,348 (29.95%) 956,422 (13.59%) 3,974,432 (56.46%) 7,039,202 (100%)
real data 1,922 (24.95%) 736 (9.56%) 5,044 (65.49%) 7,702 (100%)
randomized control 160 (23.26%) 62 (9.01%) 466 (67.73%) 688 (100%)
doi:10.1371/journal.pone.0038595.t002
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to form the receptor for leukemia inhibitory factor (LIF; not
present in our results), whose signaling is upregulated with age in
association with thymic atrophy [28]. Second, arachidonate 15-
lipoxygenase (ALOX15) is an enzyme that is upregulated in aging
rat brain [29]; it functions in production of inflammatory
leukotrienes, and may also function nonenzymatically to upregu-
late NFkB [30]. Third, several of these proteins function in blood
coagulation, markers of which increase with age and may interact
with markers of inflammation [31]. Detailed structural analysis of
these domains remains to be performed.
Table 3 also indicates that several of our hits are involved in
development, and this highlights a limitation of our data set. It is
well-known that developmental schedule and longevity have co-
evolved inmammals[1,32];thus,thesepositionsmayspecificallybe
conserved due to their effect on development, or they may
pleiotropically affect both development and adult longevity. We
did not attempt to correct for developmental schedule when fitting
thedata.Inourframework,suchcorrectionispossibleinconceptby
addingtotheregressionmodelathirdpredictorvariable,speciesage
at maturity. However, in the present set of species, we face the
problem of multicollinearity: age at maturity is too well-correlated
with MLS for correction to be a realistic goal (R
2=0.48 on n=30
species for age at female maturity after phylogenetic correction).
Additionally, no maturity data are available for three important
speciesinourset:Pteropus,Tarsius,andTupaia.Thus,itisnotpossible
to distinguish in general whether the positions found by our method
are conserved due to their roles in development, adult longevity, or
both. But most of these proteins, including our next example of
AMHR2, do have verified roles in the adult organism and may
plausibly affect longevity.
3.4. Longevity-selected Positions Cluster in the Kinase
Domain and C-terminal Tail of AMHR2
The domain containing the greatest number of longevity-
selected positions (n=7) was the protein kinase domain of
AMHR2, a protein introduced in Section 1. In human, this
domain comprises residues 203–517. Downstream of this domain
is the C-terminal tail of the protein, residues 518–573. This
cysteine-rich tail is unique to the AMHR2 ortholog family and is
predicted to lack secondary structure. On average, the residues in
the region 463–573 that do not form secondary structure have
pMLS values that are consistently in the top 2% of the 3.6 million
selected positions (median pMLS,0.568 by sliding window analy-
sis). But this trend does not hold for AMHR2 overall (median pMLS
is 0.800 excluding secondary structure positions), suggesting that
specifically the kinase C-lobe and downstream C-terminal tail of
AMHR2 are under lifespan-related selective pressure.
In sequence, five of the eight longevity-selected positions in the
kinase domain of AMHR2 concentrate in two regions near the C-
terminus of the domain (Figure 4). To determine the likely
locations of our longevity-selected positions on the structure of
AMHR2, we mapped them to the recently-solved structure of the
kinase domain of bone morphogenetic protein type 2 receptor
(BMPR2). This domain is the closest homolog to the kinase
domain of AMHR2, with 40% sequence identity. Our mapping
(Figure 5) shows that these five longevity-selected positions cluster
at or near a common surface of the AMHR2 kinase C-lobe.
Specifically, they are all located on two loops near the bottom-
front face of the domain: the aG–aH loop (Y465, T469, and F473)
and the C-terminal loop following aI (E513 and H515). All five
side-chains at least partially face solvent.
The side-chain of Y465 forms an intra-loop hydrogen bond with
R462, a conserved residue. Thus, in conjunction with P464, the
length of the Y465 side-chain constrains the angle of a second
conserved arginine, R463, which forms hydrogen bonds to
residues on aF and the aF-aG loop. Y465 is conserved in 8/9
species with MLS of at least 30 y, but in 9/19 shorter-lived species
it is instead H, F, C, N, or D, none of which (except possibly H)
can hydrogen-bond with R463 at the same angle as can Y. We
predict that these substitutions would abolish at least the hydrogen
bond with R462, destabilizing the aG–aH loop. Although the
aG–aH and C-terminal loops are both quite divergent overall and
contain several positions that did not meet our significance
criterion for longevity conservation, Y465 is the only noncon-
served residue within them whose side-chain is predicted to
interact with another residue of AMHR2.
T469 represents a position that may be differentially phosphor-
ylated, but it also highlights some current limitations of our
method and data set. T469 is the only predicted phosphorylation
site on the aG–aH loop (NetPhos score 0.692; [33]). However,
Figure 4 shows that this residue is consistently serine or threonine
in all species except shrew, where it is alanine. Substitution to a
non-phosphorylatable residue would be of biological interest, but it
is also possible that this position simply represents a genome
assembly error in shrew. This position has pMLS=0.006, making it
the least significant position of the five. Our method could exclude
it and many similar cases by adding more criteria to the position
selection process, but at the cost of decreased sensitivity and
increased complexity. We expect that the coming availability of
high-coverage de novo mammalian genome assemblies will resolve
many such cases (e.g., [34,35]).
Table 3. Selected clusters, not mutually exclusive, of ontology terms enriched in top protein domains.
functional class p examples
extracellular region 5.1e-5 BTD, CP, LAMA2, LAMA3, PRSS12
cytokine-mediated signaling pathway 0.033 JAK1, IL31RA, IL6ST, LIFR, RIKP1, KIT
protein tyrosine kinase activity 0.018 JAK1, ROS1, MST1R, NIN, OBSCN, KIT, TYK2
multicopper oxidase; copper ion binding 9.4e-3 AFP, CP, F8, HEPHL1
developmental process 0.041 AFP, AMHR2, ALOX15, CFTR, ATR, ATM, BRCA1, RECQL4
motor activity; myosin complex 0.015 KIF18B, KIF20B, KIF22, MYO5C, MYO7B, MYO18A
complement and coagulation cascades;
humoral immune response
0.061 F8, F11, CR2, C1R, CFD, LTF, CD83
serine-type endopeptidase activity 0.063 F11, C1R, CFD, KLK6, LTF, PRSS12
doi:10.1371/journal.pone.0038595.t003
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or L) in all species except guinea pig, rat, mouse, and shrew, where
it is S or C. Thus, F473 may be involved in a hydrophobic
interaction with a binding partner.
We have low confidence in the exact placement of the short C-
terminal loop, because it is not conserved in BMPR2 and lacks
contactswiththeotherelementsofourmodel.However,both E513
and H515 on this loop are preferentially charged in long-lived
species, consistent with differential binding affinity. E513 is
conserved in all species except rat, mouse, and shrew, where it is
V, G, and A. H515 is conserved positive (H or R) in 16/17 species
with MLS at least 16 y, but it is charged (H, R, or D) in only 3/9
shorter-lived species. The preference for hydrophilic residues in
long-livedspeciesatthesetwopositionsspecificallymaysuggestthat
flexibility of the C-terminal loop is a longevity-conserved property.
Most of the residues on the aG–aH loop face the solvent,
suggesting that they may interact with another domain or protein.
If this is the case, then assuming that the gross function of AMHR2
is conserved within mammals, we would expect other residues on a
common surface with the aG–aH loop to be conserved. We used
positional conservation analysis to determine conservation of the
surface residues of two alignments, (1) mammalian AMHR2
orthologs exclusively and (2) a representative set of mammalian
orthologs in the TGFBR2 subfamily, including orthologs of
TGFBR2, activin receptor type-2A and B (ACVR2A and
ACVR2B), BMPR2, and AMHR2 (not shown). This analysis
revealed two conserved solvent-facing patches flanking the region
of our longevity-selected positions. One patch, mainly comprising
the aH–aI loop, is conserved in all TGFBR2 subfamily members,
confirming a previous observation [36]. The other patch, mainly
Figure 4. OrthoMaM alignment of the C-terminal regions of AMHR2 ortholog kinase domains. Orthologs are ordered by species MLS.
The five longevity-selected positions in this region (Y465, T469, F473, E513, and H515) are highlighted in gray. ‘‘X’’ indicates regions that we masked
due to excessive divergence (Section 2.1). Long regions of gaps are not necessarily real genome deletions, but are more likely to have been missed
during genome assembly or annotation.
doi:10.1371/journal.pone.0038595.g004
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orthologs.
Overall, these findings are consistent with the existence of a
large interaction surface conserved in all AMHR2 orthologs whose
area, and thus binding affinity, varies at the aG–aH loop in a
species-specific manner. It is likely that this is a novel docking
surface involved in the regulation of AMHR2; one possible
regulatory binding partner is the C-terminal tail of AMHR2 itself,
whose positions also have consistently low pMLS values relative to
the proteome overall, as noted above. Since loop aG–aH flanks
this conserved patch, and four of the five residues face solvent in
our model, it is possible that overall these positions contribute to
lifespan-specific binding affinity.
We are unaware of reported mutations specifically in the two
loops of AMHR2 that contain our longevity-selected positions.
However, two prior lines of inquiry are consistent with the
docking-surface hypothesis. First, Belville et al. [36] also mapped
the AMHR2 kinase domain to a solved structure in order to
investigate natural mutations found in PMDS. Although based on
a structure of the more distantly-related ACVR2B instead of
BMPR2, its details are similar to those of our model, including
both overall tertiary structure and specific residue orientation. Of
the seven mutated positions they analyzed, four were located in the
C-lobe of the kinase domain. One, D491, lies in the conserved
aH–aI loop and faces solvent; its mutation to H causes PMDS.
This mutation further supports the idea that the solvent-facing
bottom of the C-lobe is critical for proper AMHR2 function.
Second, closer to the two loops on the bottom face of the
domain is the residue E485, which is in aH and also faces solvent.
In two independent population studies of Dutch women, the
mutation E485Q was associated with menopause delayed by up to
one year [37,38]. In addition to its canonical role in male fetal
development, AMHR2 also plays a second role in adult
reproductive function. It is expressed in granulosa cells of adult
females, where it seems to act as a feedback inhibitor of follicle
recruitment and growth by binding its ligand, AMH, which is
secreted in a paracrine manner specifically by more mature
follicles [11]. Follicle depletion is the cause of menopause [1], and
follicular decline or menopause has been observed in most or all
mammals studied, including whales [39,40], nonhuman primates
[41], rodents, and others [1,42], although admittedly we lack data
for most species in the wild. A reasonable deduction is that a
species’s rate of follicle depletion scales inversely with its longevity.
We speculate that differential regulation of AMHR2 in a lifespan-
dependent manner could act as a mechanism that effects this
scaling, increasing the probability that a female has used all her
reproductive potential before her death. This hypothesis could be
viewed as a case of the disposable soma theory of aging [43]. It
might be tested by relating AMHR2 ortholog sequence to rate of
follicular decline across several species.
We also note the unusual cysteine conservation in the C-
terminal tail, which is unique to AMHR2 orthologs. There are
eight cysteine residues in this region of human AMHR2, all of
which are relatively conserved. Multiple regression revealed a
specific fit of the number of cysteines conserved to log10 MLS
(pMLS=0.002 and pmass=0.082 after phylogenetic correction). It is
possible that these residues bind zinc or another metal ion, thus
imparting structure to this region, but the region does not match
known zinc finger motifs.
3.5. Comparison with Previous Methods
Generally, we did not observe overlap between the longevity-
selected proteins we identified and those identified in previous
work [4,5]. But this is not surprising, because we differed in our
assumptions, goals, and data sets (detailed in Sections 1 and 2.1).
Most notably, we fit a smaller subset of high-quality protein
alignments, focused on structured protein regions, and chose to
ignore synonymous codon substitutions. Thus, we view our results
as complementary, not conflicting. We do note that both our
method and that of Li and de Magalha ˜es [5] identified ‘‘myosin
complex’’ as an ontology term enriched in longevity-selected
proteins (Table 3). The two methods also agreed that two proteins
were longevity selected, rho guanine nucleotide exchange factor 16
(ARHGEF16) and lymphokine-activated killer T-cell-originated
Figure 5. AMHR2 kinase domain mapped onto experimental structure of BMPR2 kinase domain. All eight longevity-selected positions
found in this domain are shown as black sticks and are further described in Table S2. The five longevity-selected positions discussed in the text are
labeled; they are found on the aG–aH loop (Y465, T469, and F473) and the C-terminal loop following aI (E513 and H515).
doi:10.1371/journal.pone.0038595.g005
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involved in cell migration [44], there may be lifespan-specific
differences in this activity, or our findings may simply reflect its
standard role in organismal development.
One apparent novelty of our method is that it allows analysis of
individual positions in the proteome, not just entire proteins. In
fact, this is not novel, as the method of Jobson et al. [4] also entails
identification of specific longevity-selected positions, and the genes
they called ‘‘longevity-selected’’ and ‘‘longevity-relaxed’’ were
simply genes with statistical over- or under-abundances of such
positions. Here, we have emphasized individual positions rather
than entire proteins for three reasons. First, we think it plausible,
as did Jobson et al., that a mark of a longevity-selected protein is
an abundance of longevity-selected positions. Second, a focus on
individual positions allows to more precisely determine arbitrary
regions of a protein that may be longevity-selected, as exemplified
by the C-terminus of AMHR2. In theory, such specific focus can
suggest novel biochemical mechanisms. Third, since aging is a
complex trait that is under weak selection, it is plausible that some
major determinants are subtle general properties of the proteome
itself (discussed in Section 3.2), rather than the explicit activity of a
single protein or even a few functional collections of proteins.
Longevity-selected positions are the most obvious markers of such
properties, and so may provide clues to identify them, in the same
way as they may identify individual longevity-selected proteins. In
short, we do not suggest that the positions that we call longevity-
selected, in isolation, are major determinants of mammalian
longevity. We only suggest that they may mark proteins or
proteomic features that are such determinants, but are less obvious.
For detecting longevity-selected protein positions, benefits of our
method versus standard codon-level methods such as the codeml
program of PAML [45] include emphasis on detection of
significant biochemical changes that are likely to affect protein
structure; straightforward single-position resolution, allowing to
easily test hypotheses regarding arbitrary regions of proteins, as
described above; simple control for species-specific mutation rate
and shared phylogeny and fitting of body mass as an alternate
hypothesis to MLS; avoidance of the need to arbitrarily bin species
by MLS; and faster run time. We reiterate that our method in
theory is compatible with any quantitative trait, as illustrated by
our inclusion of both MLS and body mass, although in practice
correlations between predictor variables in the data limit the
application of this for the predictors of greatest interest, such as
developmental schedule (Section 3.3). However, this is a limitation
that our approach shares with the others, given the set of species
available. Some unique drawbacks of our method, in addition to
those described in Section 3.4, include its reliance on a single
reference proteome and lack of a specific model of protein
evolution, implying unsuitability for rigorous statistical hypothesis-
testing. It is a task for future work to combine the benefits of our
method with those of standard codon model-based methods.
3.6. Conclusion
Based on principles of protein structure, we have developed a
simple, extensible, and gerontologically-oriented method to find
longevity-selected positions in the mammalian proteome. Using
this method we found that, surprisingly, longevity-selected
positions are much more common in the mammalian proteome
than would be expected based on a randomized control. We have
also used our method to identify specific protein regions that
deserve further study in the context of the comparative biology of
aging and development, as well as specific aging-related proteins
that are likely not lifespan-conserved due to their overall
conservation. Topping the list of regions worth further study is
the kinase domain and C-terminal tail of AMHR2, in which the
longevity-selected residues lie on a common surface of unknown
functional significance. Our results must be considered in light of
the flaws we described in the method, the high error and omission
rates of the mammalian proteome data that we used, and most of
all the obvious limitations inherent in using the set of putative
orthologs from a single individual’s genome to represent the
proteome of an entire species. Given those caveats, we have found
our method to be a reasonable starting point for comparative
analysis of protein function.
Supporting Information
Figure S1 Density histograms of pMLS values yielded by
fitting alternate input sets with the method described in
Section 2.2. As in Figure 3, only fit positions with bMLS.0
are included. A. Chimp (Pan troglodytes) is the reference, and
human is absent. B. Rhesus (Macaca mulatta) is the only primate fit.
Human is the reference. C. Dog (Canis lupus) is the reference. D.
Scores taken from BLOSUM62 instead of BLOSUM80. Real
data. E. Randomized control data for (D).
(EPS)
Table S1 The 107 protein domains that contain at least
two longevity-selected positions.
(XLS)
Table S2 Longevity-selected positions of the protein
domains shown in Table S1.
(XLS)
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